Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcasynn Pharmaceuticals GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9401728Aexternal-prioritypatent/SE9401728D0/xx
Application filed by IndividualfiledCriticalIndividual
Publication of CA2189140A1publicationCriticalpatent/CA2189140A1/fr
Application grantedgrantedCritical
Publication of CA2189140CpublicationCriticalpatent/CA2189140C/fr
Use of 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives for combating endoparasites, new 3-aryl-substituted 5-alkyl-isoxazole-4-carboxylic acid derivatives, and process for their preparation
Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses